GLOBAL STROKE CARE TAKES A HIT DURING THE PANDEMIC
(MedPage Today) -- The COVID-19 pandemic was linked with a global decline in the volume of stroke hospitalizations, intravenous thrombolysis (IVT), and interfacility IVT transfers, a researcher reported.
From March to June 2020, stroke admissions..
FDA REVOKES EUA FOR MONOCLONAL ANTIBODY THERAPY BAMLANIVIMAB TO TREAT PATIENTS WITH COVID-19
Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients.
COMMON MS TREATMENT WEARS OFF MORE QUICKLY IN BLACK PATIENTS
Black patients with multiple sclerosis or neuromyelitis optica spectrum disorder may respond differently to a common MS therapy compared to their White peers, new research suggests.